challenging “Good Cancer” Myth: What Patients and Clinicians Need to Know

Dr. Lori Wirth, MD—Elizabeth and Michael Ruane Chair of Endocrine Oncology; Medical Director of the Massachusetts General Hospital Center for Head and Neck Cancers; and Professor of Medicine at Harvard…

Continue Readingchallenging “Good Cancer” Myth: What Patients and Clinicians Need to Know

Liquid Biopsies in Neo-Adjuvant Head & Neck Cancer: Personalizing Therapy, Reducing Toxicity

We are privileged to have Dr. Ari Rosenberg, MD, and Dr. Maha Elsebaie, MD, MSc, from the University of Chicago, join us to discuss groundbreaking research in neoadjuvant head and…

Continue ReadingLiquid Biopsies in Neo-Adjuvant Head & Neck Cancer: Personalizing Therapy, Reducing Toxicity

C-POST Trial Results: Adjuvant Immunotherapy (Cemiplimab) in Cutaneous SCC with Dr. Danny Rischin, MD

In a recent episode of MedInsights Unleashed, Dr. Danny Rischin, MD, medical oncologist/clinician researcher at the Peter MacCallum Cancer Centre and Professor, Sir Peter MacCallum Department of Oncology, University of…

Continue ReadingC-POST Trial Results: Adjuvant Immunotherapy (Cemiplimab) in Cutaneous SCC with Dr. Danny Rischin, MD